This program provides an in-depth examination of metastatic colon cancer management, emphasizing current treatment protocols, molecular targets, and the role of immunotherapies. Participants will gain insights into the latest systemic therapies and learn how to incorporate genetic profiling into treatment decisions. The course also covers the significance of RAS and BRAF mutations, HER2 amplification, and explores the evolving role of immunotherapy, particularly in patients with specific genetic profiles.
- Provider:Horizon CME, Inc.
- Activity Link: http://default/node/2792
- Start Date: 2025-01-22 06:00:00
- End Date: 2025-01-22 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest